Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 2-chloro-5-thiophenecarboxylic acid via chlorination and oxidation. High-yield route for Razaxaban intermediates with reduced environmental impact.
Discover the novel TiCl4-catalyzed synthesis of N-heteroatom polycyclic indolizines. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN121181461A details a high-yield acetic acid catalyzed route for pyrrolidone intermediates, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN113039175A reveals a scalable catalytic route for arylsulfonyl acrylonitriles, offering cost-effective and environmentally benign manufacturing solutions for global supply chains.
Novel methanol-based methylation method replaces toxic reagents. Offers high purity, green chemistry compliance, and scalable production for pharmaceutical intermediates.
Patent CN111704555A reveals a safer continuous flow method for 4-methoxy-2-nitroaniline. Achieve >99% purity and reduced costs in omeprazole intermediate manufacturing.
Novel synthesis of Erlotinib HCl via 3,4-dihydroxybenzaldehyde avoids demethylation steps, offering cost-effective industrial scale-up for pharmaceutical intermediates.
Patent CN113292563B reveals a mild Pd-catalyzed C-H bisacetoxylation method for pyrrolo[2,3-d]pyrimidines, offering reliable pharmaceutical intermediate supply and cost reduction.
Novel Pd-catalyzed C-H activation method for high-purity indole intermediates. Reduces steps and cost for pharmaceutical manufacturing supply chains.
Patent CN102070626B details a novel two-step etherification route for Iloperidone, offering high purity and cost reduction in API manufacturing through improved regioselectivity.
Patent CN110714208B details a metal-free electrochemical route for phenanthridine derivatives, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN102898356A details a scalable route for Prucalopride intermediates. Discover cost-effective hydrogenation strategies and supply chain advantages for API manufacturing.
Advanced O-protected synthesis route for HI-6 dimethanesulfonate. Eliminates toxic reagents, improves yield, and ensures high purity for nerve agent antidote manufacturing.
Patent CN100422154C reveals a high-purity synthesis route for 3-methylquinoline-8-sulfonyl chloride, optimizing Argatroban production with superior yield and reduced isomers.
Patent CN111978219B details a novel Cu-OMS-2 catalyzed C-S coupling for diaryl sulfides. Discover cost-effective API intermediate manufacturing solutions.
Patent CN112824374B details a nickel-catalyzed asymmetric hydrogenation method for chiral amines, offering cost-effective alternatives to precious metals for pharmaceutical intermediates.
Patent CN116217513A reveals a green water-based microwave method for benzothiazoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102993065B details a novel Lewis acid-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN110835341A details a mild oxidative coupling method for tetrahydrocarboline derivatives with high yields, offering cost-effective routes for antitumor drug development.